These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 4269214)

  • 21. Proceedings: The effects of the anticonvulsant ethosuximide on adenosine triphosphatase activities of synaptosomes prepared from rat cerebral cortex.
    Gilbert JC; Wyllie MG
    Br J Pharmacol; 1974 Sep; 52(1):139P-140P. PubMed ID: 4281338
    [No Abstract]   [Full Text] [Related]  

  • 22. Early biochemical changes in phytohemagglutinin-stimulated human lymphocytes of blood and lymph.
    Stjernholm RL; Falor WH
    J Reticuloendothel Soc; 1970 Apr; 7(4):471-83. PubMed ID: 5435833
    [No Abstract]   [Full Text] [Related]  

  • 23. Some studies on the convulsant action of folic acid.
    Baxter MG; Miller AA; Webster RA
    Br J Pharmacol; 1973 Jun; 48(2):350P-351P. PubMed ID: 4733748
    [No Abstract]   [Full Text] [Related]  

  • 24. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
    Temmink OH; Hoogeland MF; Fukushima M; Peters GJ
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):171-9. PubMed ID: 16010590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticonvulsant drugs, folic acid metabolism, fit frequency and psychiatric illness.
    Reynolds EH
    Psychiatr Neurol Neurochir; 1971; 74(2):167-74. PubMed ID: 4948428
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenytoin, folates, and A.T.P.ase.
    Viukari NM
    Lancet; 1970 May; 1(7654):1000-1. PubMed ID: 4191914
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin.
    Haque N; Thrasher K; Werk EE; Knowles HC; Sholiton LJ
    J Clin Endocrinol Metab; 1972 Jan; 34(1):44-50. PubMed ID: 5008232
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro inhibition study of diphenylhydantoin upon rat liver enzymes in folic acid metabolism.
    Narisawa K; Honda Y; Yoshida T; Arakawa T
    Tohoku J Exp Med; 1972 Mar; 106(3):249-51. PubMed ID: 4402619
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of 5,5-diphenylhydantoin and related carbamates and hydroxylamines on nucleic acid and protein synthesis of proliferating human lymphocytes.
    MacKinney AA; Vyas R
    Toxicol Appl Pharmacol; 1975 Jul; 33(1):38-45. PubMed ID: 1162703
    [No Abstract]   [Full Text] [Related]  

  • 30. Growth promotion in Tetrahymena by folic acid analogs.
    KIDDER GW; DEWEY VC; PARKS RE
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):88-91. PubMed ID: 14891929
    [No Abstract]   [Full Text] [Related]  

  • 31. Folic acid and the half-life of diphenylhydantoin in man.
    Andreasen PB; Hansen JM; Skovsted L; Siersbaek-Nielsen K
    Acta Neurol Scand; 1971; 47(1):117-9. PubMed ID: 5576217
    [No Abstract]   [Full Text] [Related]  

  • 32. Folic acid polyglutamate conjugase activity in liver of rats receiving diphenylhydantoin.
    Honda Y; Arakawa T
    Tohoku J Exp Med; 1974 Jun; 113(2):197-9. PubMed ID: 4439404
    [No Abstract]   [Full Text] [Related]  

  • 33. The biosynthesis of folic acid compounds in plants. V. Reaction mechanism of the dihydropteroate-synthesizing enzyme from pea seedlings.
    Okinaka O; Iwai K
    J Vitaminol (Kyoto); 1970 Sep; 16(3):210-4. PubMed ID: 4248394
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-folic acid activity of antiepileptic drugs. II. Experimental studies in rats.
    Patil KP; Chitre RG; Sheth UK
    Indian J Med Sci; 1966 Sep; 20(9):623-7. PubMed ID: 5975730
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic lupus erythematous triggered by diphenylhydantoin.
    Gleichman H
    Arthritis Rheum; 1982 Nov; 25(11):1387-8. PubMed ID: 7138611
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic-gingival hyperplasia: in vivo and in vitro study.
    Ieiri I; Goto W; Hirata K; Toshitani A; Imayama S; Ohyama Y; Yamada H; Ohtsubo K; Higuchi S
    Eur J Clin Pharmacol; 1995; 49(1-2):51-6. PubMed ID: 8751021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological adverse effects of anticonvulsants. What is their clinical relevance?
    De Ponti F; Lecchini S; Cosentino M; Castelletti CM; Malesci A; Frigo GM
    Drug Saf; 1993 Mar; 8(3):235-50. PubMed ID: 8452664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of therapeutic drugs on lymphocyte transformation.
    Williams WR; Davidson LA
    Br J Clin Pharmacol; 1983 Jan; 15(1):83-90. PubMed ID: 6849749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diphenylhydantoin (DPH) blocks HIV-receptor on T-lymphocyte surface.
    Zimmer JP; Lehr HA; Kornhuber ME; Breitig D; Montagnier L; Gietzen K
    Blut; 1986 Dec; 53(6):447-50. PubMed ID: 3492229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assay of diphenylhydantoin effects on growing human lymphocytes.
    MacKinney AA; Vas R
    J Pharmacol Exp Ther; 1973 Jul; 186(1):37-43. PubMed ID: 4269214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.